ANTIKÖRPER GEGEN AMYLOID BETA
European patent · EP3574020 · In force
Register entry
- Publication number
- EP3574020
- Application number
- EP18835520
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 18, 2018
- Published
- Dec 4, 2019
- Granted
- May 15, 2024
- Protection ends at the latest
- Jul 17, 2038
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C07K 16/46 (2006.01)A61K 39/395 (2006.01)A61K 47/68 (2017.01)A61K 49/00 (2006.01)A61K 51/10 (2006.01)C07K 16/18 (2006.01)C12N 15/13 (2006.01)C12N 5/16 (2006.01)G01N 33/53 (2006.01)
- Priority
- WO PCT/CA2017/050866 18.07.2017US 201715808842 09.11.2017US 201862622126 P 25.01.2018
- PCT application
- PCT/CA2018/050875 18.07.2018
- PCT publication
- WO2019/014768 24.01.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
- Mar 26, 2025
Change
Published in Swissreg on 26.03.2025
- Sep 2, 2024
Next annual fee due on
- Next annual fee due on
- 31.07.2024 → 31.07.2025
Published in Swissreg on 02.09.2024
- Jul 30, 2024
Agent entered
- Representative
- Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex
Published in Swissreg on 30.07.2024
- May 15, 2024
Granted
Published in Swissreg on 15.05.2024
Parties
Holder
Inventor
Sherborn, Massachusetts 01770, US
Whistler, British Columbia V0N 1B4, CA
Vancouver, British Columbia V6S 1M8, CA
Port Moody, British Columbia V3H 5J5, CA
Vancouver, British Columbia V5Z 1C3, CA
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.